{"count": 4, "results": [{"_id": "9549290", "pmid": 9549290, "title": "[Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline].", "journal": "Minerva Cardioangiol", "authors": ["D'Amelio A", "Bonucchi D", "Patruno P", "Ballestri M", "Mastrangelo F"], "date": "1997-11-01T00:00:00Z", "meta_date_publication": "1997 Nov", "meta_volume": "45", "meta_issue": "11", "meta_pages": "567-72", "score": 50090.316, "text_hl": "[Treatment of post-transplant @<m>DISEASE_Polycythemia</m> @DISEASE_MESH:D011086 @@@erythrocytosis@@@: comparison of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Theophylline @CHEMICAL_MESH:D013806 @@@theophylline@@@].", "citations": {"NLM": "D'Amelio A, Bonucchi D, Patruno P, Ballestri M, Mastrangelo F. [Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline]. Minerva Cardioangiol. 1997 Nov;45(11):567-72. PMID: 9549290", "BibTeX": "@article{9549290, title={[Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline].}, author={D'Amelio A and Bonucchi D and Patruno P and Ballestri M and Mastrangelo F}, journal={Minerva Cardioangiol}, volume={45}, number={11}, pages={567-72}}"}}, {"_id": "8938674", "pmid": 8938674, "title": "Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.", "journal": "Nephron", "authors": ["MacGregor MS", "Rowe PA", "Watson MA", "Rodger RS", "Junor BJ", "Briggs JD"], "date": "1996-01-01T00:00:00Z", "doi": "10.1159/000189445", "meta_date_publication": "1996", "meta_volume": "74", "meta_issue": "3", "meta_pages": "517-21", "score": 50075.527, "text_hl": "Fifty-two @SPECIES_9606 @@@patients@@@ with postrenal transplant @<m>DISEASE_Polycythemia</m> @DISEASE_MESH:D011086 @@@erythrocytosis@@@ were treated with an angiotensin-converting enzyme inhibitor (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ or @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@) for a median of 13 months (range 0-44). ", "citations": {"NLM": "MacGregor MS, Rowe PA, Watson MA, Rodger RS, Junor BJ, Briggs JD. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors. Nephron. 1996;74(3):517-21. PMID: 8938674", "BibTeX": "@article{8938674, title={Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.}, author={MacGregor MS and Rowe PA and Watson MA and Rodger RS and Junor BJ and Briggs JD}, journal={Nephron}, volume={74}, number={3}, pages={517-21}}"}}, {"_id": "12070465", "pmid": 12070465, "title": "[Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].", "journal": "Minerva Urol Nefrol", "authors": ["Morale W", "Puliatti C", "Veroux P", "Veroux M", "Valvo C", "Cappello D", "Puliatti D", "Francesco L"], "date": "2002-06-01T00:00:00Z", "meta_date_publication": "2002 Jun", "meta_volume": "54", "meta_issue": "2", "meta_pages": "145-8", "score": 50073.86, "text_hl": "CONCLUSIONS: @GENE_AP2B1 @GENE_163 @@@ACE@@@-inhibitors (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@) or alternatively the use of angiotensin II receptor antagonists, like @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@, at low doses, is an effective and safe treatment for @SPECIES_9606 @@@patients@@@ developing @<m>DISEASE_Polycythemia</m> @DISEASE_MESH:D011086 @@@post-transplantation erythrocytosis@@@ (@<m>DISEASE_Polycythemia</m> @DISEASE_MESH:D011086 @@@PTE@@@).", "citations": {"NLM": "Morale W, Puliatti C, Veroux P, Veroux M, Valvo C, Cappello D, Puliatti D, Francesco L. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors]. Minerva Urol Nefrol. 2002 Jun;54(2):145-8. PMID: 12070465", "BibTeX": "@article{12070465, title={[Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].}, author={Morale W and Puliatti C and Veroux P and Veroux M and Valvo C and Cappello D and Puliatti D and Francesco L}, journal={Minerva Urol Nefrol}, volume={54}, number={2}, pages={145-8}}"}}, {"_id": "12384621", "pmid": 12384621, "title": "[Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].", "journal": "Minerva Urol Nefrol", "authors": ["Morale W", "Puliatti C", "Veroux P", "Veroux M", "Valvo C", "Cappello D", "Puliatti D", "Francesco L"], "date": "2002-09-01T00:00:00Z", "meta_date_publication": "2002 Sep", "meta_volume": "54", "meta_issue": "3", "meta_pages": "189-92", "score": 50073.734, "text_hl": "CONCLUSIONS: @GENE_AP2B1 @GENE_163 @@@ACE@@@-inhibitors (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@) or alternatively the use of angiotensin II receptor antagonists, like Iosartan at low doses, is an effective and safe treatment for @SPECIES_9606 @@@patients@@@ developing @<m>DISEASE_Polycythemia</m> @DISEASE_MESH:D011086 @@@post-transplantation erythrocytosis@@@ (@<m>DISEASE_Polycythemia</m> @DISEASE_MESH:D011086 @@@PTE@@@).", "citations": {"NLM": "Morale W, Puliatti C, Veroux P, Veroux M, Valvo C, Cappello D, Puliatti D, Francesco L. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors]. Minerva Urol Nefrol. 2002 Sep;54(3):189-92. PMID: 12384621", "BibTeX": "@article{12384621, title={[Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].}, author={Morale W and Puliatti C and Veroux P and Veroux M and Valvo C and Cappello D and Puliatti D and Francesco L}, journal={Minerva Urol Nefrol}, volume={54}, number={3}, pages={189-92}}"}}]}